Nebentan can be used in research related to the improvement of cor pulmonale and myocardial infarction; it significantly inhibits the progression of pulmonary hypertension and the development of right ventricular hypertrophy; it ameliorates the poor survival rate in congestive heart failure (CHF) rats and markedly reduces biventricular hypertrophy and pulmonary congestion.